136 related articles for article (PubMed ID: 11271339)
1. FK 506 rescue therapy for intractable liver allograft rejection.
Wong P; Devlin J; Gane E; Ramage J; Portmann B; Williams R
Transpl Int; 1994; 7 Suppl 1():S70-6. PubMed ID: 11271339
[TBL] [Abstract][Full Text] [Related]
2. FK 506 therapy for refractory renal allograft rejection: lessons from liver transplantation.
Woodle ES; Bruce DS; Josephson M; Newell KA; Piper JB; Millis JM; Cronin D; Whitman G; Ruebe M; Thistlethwaite JR
Clin Transplant; 1996 Aug; 10(4):323-32. PubMed ID: 8884103
[TBL] [Abstract][Full Text] [Related]
3. Focus on intractable rejection: 6-month results of the European multicentre liver study of FK 506 and cyclosporin A.
Bismuth H; Samuel D; Neuhaus P; McMaster P; Calne R; Pichlmayr R; Otto G; Williams R; Groth C
Transpl Int; 1994; 7 Suppl 1():S3-6. PubMed ID: 11271231
[TBL] [Abstract][Full Text] [Related]
4. FK 506 rescue therapy for hepatic allograft rejection: experience with an aggressive approach.
Woodle ES; Perdrizet GA; So SK; White HM; Marsh JW
Clin Transplant; 1995 Feb; 9(1):45-52. PubMed ID: 7537988
[TBL] [Abstract][Full Text] [Related]
5. FK 506 treatment of intractable rejection after liver transplantation.
Jost U; Winkler M; Ringe B; Rodeck B; Pichlmayr R
Transplant Proc; 1993 Aug; 25(4):2686-7. PubMed ID: 7689276
[No Abstract] [Full Text] [Related]
6. Conversion of liver allograft recipients from cyclosporine A to FK 506 immunosuppressive therapy.
Ben-Ari Z; Mor E; Shaharabani E; Bar-Nathan N; Shapira Z; Tur-Kaspa R
Transplant Proc; 2000 Jun; 32(4):709-10. PubMed ID: 10856553
[No Abstract] [Full Text] [Related]
7. Recurrent rejection following FK 506 rescue therapy for acute hepatic allograft rejection.
Woodle ES; So S; Jendrisak MD; Perdrizet GA; White HM; Marsh JW
Transplant Proc; 1993 Apr; 25(2):1988-9. PubMed ID: 7682358
[No Abstract] [Full Text] [Related]
8. FK 506 primary immunosuppression following emergency liver transplantation for fulminant hepatic failure. European FK 506 Study Liver Group.
Devlin J; Wong P; Williams R; Neuhaus P; McMaster P; Calne R; Pichlmayr R; Otto G; Bismuth H; Groth C
Transpl Int; 1994; 7 Suppl 1():S64-9. PubMed ID: 11271328
[TBL] [Abstract][Full Text] [Related]
9. A multicenter trial of FK506 (tacrolimus) therapy in refractory acute renal allograft rejection. A report of the Tacrolimus Kidney Transplantation Rescue Study Group.
Woodle ES; Thistlethwaite JR; Gordon JH; Laskow D; Deierhoi MH; Burdick J; Pirsch JD; Sollinger H; Vincenti F; Burrows L; Schwartz B; Danovitch GM; Wilkinson AH; Shaffer D; Simpson MA; Freeman RB; Rohrer RJ; Mendez R; Aswad S; Munn SR; Wiesner RH; Delmonico FL; Neylan J; Whelchel J
Transplantation; 1996 Sep; 62(5):594-9. PubMed ID: 8830821
[TBL] [Abstract][Full Text] [Related]
10. Mycophenolate mofetil rescue therapy in patients with chronic hepatic allograft rejection.
Kato T; Ruiz P; DeFaria W; Weppler D; Khan F; Pinna A; Nery J; Tzakis A
Transplant Proc; 1999; 31(1-2):396. PubMed ID: 10083158
[No Abstract] [Full Text] [Related]
11. FK 506 and mycofenolate mofetil rescue for acute steroid-resistant and chronic rejection after liver transplantation.
Platz KP; Mueller AR; Neuhaus R; Keck HH; Lobeck H; Neuhaus P
Transplant Proc; 1997 Nov; 29(7):2872-4. PubMed ID: 9365598
[No Abstract] [Full Text] [Related]
12. Incidence and outcome of chronic rejection in CyA- and FK 506-treated patients.
Platz KP; Tullius SG; Mueller AR; Schumacher G; Nüssler N; Neuhaus R; Bechstein WO; Lobeck H; Neuhaus P
Transplant Proc; 1996 Dec; 28(6):3183-4. PubMed ID: 8962235
[No Abstract] [Full Text] [Related]
13. Use of Prograf (FK 506) as rescue therapy for refractory rejection after liver transplantation. US Multicenter FK 506 Liver Study Group.
Klintmalm GB; Goldstein R; Gonwa T; Wiesner RH; Krom RA; Shaw BW; Stratta R; Ascher NL; Roberts JW; Lake J
Transplant Proc; 1993 Feb; 25(1 Pt 1):679-88. PubMed ID: 7679840
[TBL] [Abstract][Full Text] [Related]
14. FK506 conversion for intractable rejection of the liver allograft.
McDiarmid SV; Klintmalm GB; Busuttil RW
Transpl Int; 1993; 6(6):305-12. PubMed ID: 7507675
[TBL] [Abstract][Full Text] [Related]
15. Conversion to tacrolimus after liver transplantation.
Jonas S; Bechstein WO; Lemmens HP; Kling N; Grauhan O; Lobeck H; Neuhaus P
Transpl Int; 1996; 9(1):23-31. PubMed ID: 8748407
[TBL] [Abstract][Full Text] [Related]
16. Prognostic factors for successful conversion from cyclosporine to FK 506-based immunosuppressive therapy for refractory rejection after liver transplantation. US Multicenter FK 506 Liver Study Group.
Klintmalm GB; Goldstein R; Gonwa T; Wiesner RH; Krom RA; Shaw BW; Stratta R; Ascher NL; Roberts JW; Lake J
Transplant Proc; 1993 Feb; 25(1 Pt 1):641-3. PubMed ID: 7679828
[No Abstract] [Full Text] [Related]
17. FK 506 rescue therapy: early conversion improves efficacy.
Woodle ES; Perdrizet GA; So S; Jendrisak MD; White HM; Marsh JW
Transplant Proc; 1993 Apr; 25(2):1990-1. PubMed ID: 7682359
[No Abstract] [Full Text] [Related]
18. Successful use of tacrolimus for initial rejection episodes after liver transplantation.
Millis JM; Cronin DC; Newell KA; Bruce DS; Woodle ES; Grewal HP; Loss GE; Lissoos T; Conjeevaram H; Schiano T; O'Laughlin R; Charette J; McNaughton M; Baker AL; Thistlethwaite JR
Transplant Proc; 1998 Jun; 30(4):1407-8. PubMed ID: 9636569
[No Abstract] [Full Text] [Related]
19. Tacrolimus (FK 506) for rescue of chronic rejection following orthotopic liver transplantation.
Sher LS; Cosenza CA; Petrovic LM; Rojter S; Hoffman A; Lopez RR; Meehan M; Pan SH; Vierling J; Makowka L
Transplant Proc; 1996 Apr; 28(2):1011-3. PubMed ID: 8623212
[No Abstract] [Full Text] [Related]
20. FK 506 rescue therapy: the rapidity of rejection reversal is related to the subsequent development of CMV disease.
Woodle ES; Perdrizet GA; So S; Jendrisak MD; White HM; Marsh JW
Transplant Proc; 1993 Apr; 25(2):1992-3. PubMed ID: 7682360
[No Abstract] [Full Text] [Related]
[Next] [New Search]
